Table 2.
Features of autoimmunity shared by different autoimmunity-inducing drugs and chemicals.
| Drugs/Chemicals | Mechanism | References |
|---|---|---|
| Silica/Asbestos | Adjuvant effect | 21 |
| T regulatory cells | 33 | |
| Inflammasome (NLRP3a, IL-1β) | 28 | |
| Exacerbates lupus-prone genotype | 32 | |
| Heavy Metals (Hg, Ag, Au) | T cell activation threshold | 86 |
| T regulatory cells | 80 | |
| Inflammasome (NLRP3a, IL-1β) | Toomey and Pollard (unpublished) | |
| Exacerbates lupus-prone genotype | 76, 108 | |
| Drugs (procainamide) | T cell activation threshold | 12 |
| Central tolerance | 18 | |
| TCDD, dioxinb | Central tolerance | 152 |
| Aryl hydrocarbon receptor | 150 | |
| T regulatory cells | 150 | |
| Adjuvant oils (pristane) | Adjuvant effect | 134 |
| Exacerbates lupus-prone genotype | 135 | |
| Pesticides/Fungicides (Hexachlorobenzene) | Adjuvant effect | 162 |
| Exacerbates lupus-prone genotype | 164 | |
| Adulterated rapseed oil | Exacerbates lupus-prone genotype | 44 |
| Iodine | T regulatory cells | 110 |
| Trichloroethylene (TCE) | Exacerbates lupus-prone genotype | 153 |
NOD-like receptor family, pryin domain containing 3
2,3,7,8-Tetrachlorodibenzo-p-dioxin